Hepion Pharmaceuticals Enters Securities Purchase Agreement

Hepion Pharmaceuticals, Inc. has entered into a Securities Purchase Agreement with various purchasers. Under this agreement, the company intends to issue and sell its securities to these purchasers. The transaction is structured as a private placement, utilizing exemptions from registration requirements under Section 4(a)(2) and/or Regulation D of the Securities Act.